the Web site devoted to the study of the glucagon-like peptides

This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Lunenfeld-Tanenbaum Research Institute   University of Toronto

@DanielJDrucker   

 

 

Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor

agonists and sodium-glucose cotransporter 2 inhibitors

 

 

 

Semaglutide, atherosclerosis and hepatosteatosis-new insights

 

 

 

 

 

 

 

 

Semaglutide Exposure Response

Pharmacodynamics

 

 

 

 

 

 

 

THE DISCOVERY OF INSULIN   

 

 

 

 

 

COVID-19 Cell Metabolism 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


WWW glucagon.com